Tesamorelin/Ipamorelin is a dual-peptide research blend combining a GHRH analogue with a selective ghrelin receptor peptide for laboratory studies focused on synergistic growth hormone signaling, endocrine pathway communication, and metabolic regulation research. Tesamorelin is studied for its GHRH-pathway activity and lipolytic signaling, while Ipamorelin is examined for its. Together, they provide a complementary platform for investigating pulsatile GH dynamics, peptide synergy, and downstream endocrine and metabolic pathway effects. This product is supplied as a research blend for controlled laboratory handling by qualified professionals.
Compound: Tesamorelin + Ipamorelin Composition: Tesamorelin (2mg) + Ipamorelin (2mg) Total Content: 4mg blend per vial Form: Research peptide blend Storage: Store in a cool, dry environment. Protect from heat, moisture, and direct light.
Synergistic GH signaling studies GHRH and ghrelin receptor pathway analysis Metabolic and lipolytic pathway research Dual-peptide endocrine synergy investigations
This material is supplied exclusively for laboratory research use by qualified professionals. It is not intended for human or animal consumption, and must not be used in food, drugs, cosmetics, or diagnostic applications. All handling and use should comply with applicable laws, regulations, and institutional protocols.
